Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroPort NeuroScientificHKSE:02172 -1.37%93 EBITDA Margin % is 28.92% as of Dec. 2025, which is 13% below its 10-year median of 33.29. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.19 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 89.83% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MicroPort NeuroScientific EBITDA Margin % Related Terms
MicroPort NeuroScientific EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02172 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, MicroPort NeuroScientific's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroScientific EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroScientific's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroPort NeuroScientific (HKSE:02172) has a EBITDA Margin % of 28.92% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MicroPort NeuroScientific and its competitors. This is 13% below median its historical median of 33.29. Over the past decade, MicroPort NeuroScientific's EBITDA Margin % has ranged from 27.71 to 47.79. According to the industry distribution chart, MicroPort NeuroScientific ranks #83 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 10.2%.
Is MicroPort NeuroScientific's EBITDA Margin % too high?
MicroPort NeuroScientific's current EBITDA Margin % of 28.92% is 13% below median its 10-year median of 33.29. Over the past 10 years, this metric has ranged from a low of 27.71 to a high of 47.79. The Medical Devices & Instruments industry median EBITDA Margin % is 7.59. MicroPort NeuroScientific's value of 28.92% is 281% above this industry median. Based on the distribution chart, MicroPort NeuroScientific ranks #83 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #83 out of 816 companies for EBITDA Margin %. This places MicroPort NeuroScientific in the top 10% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.59. MicroPort NeuroScientific's value of 28.92% is 281% above this benchmark. Historically, MicroPort NeuroScientific's own EBITDA Margin % has ranged from 27.71 to 47.79 over the past decade. While the company's 10-year median is 33.29 vs. the industry median of 7.59, MicroPort NeuroScientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.59, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroPort NeuroScientific's current EBITDA Margin % of 28.92% is 281% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MicroPort NeuroScientific and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort NeuroScientific's current EBITDA Margin % is 28.92%, which is 13% below median its own 10-year median of 33.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.19, compared to a current price of HK$9.01 — trading 31.7% below its estimated fair value. The current EBITDA Margin % is 28.92%, which is 13% below median its 10-year median of 33.29 and 281% above the Medical Devices & Instruments industry median of 7.59. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current EBITDA Margin % is 28.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued.
The current stock price of HK$9.01 is trading 31.7% below its estimated GF Value™ of HK$13.19.
GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.
Key valuation signals for HKSE:02172:
EBITDA Margin %: 28.92% (13% below median its 10-year median of 33.29)
GF Value™: HK$13.19 vs. price of HK$9.01 (31.7% below fair value)
Industry Position: 281% above the Medical Devices & Instruments median (#83 of 816)
No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score
Get the complete analysis for HKSE:02172
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02172 has been successfully added to your 
